Turcot综合征1例

摘要/Abstract

摘要：

Turcot综合征是一种罕见的遗传性疾病,以中枢神经系统原发肿瘤伴结直肠腺瘤性息肉或结直肠癌为特征,现报道1例Turcot综合征的诊疗情况并文献复习,以此提高对该类疾病的认识,实现早期检测和治疗。

韩宇星, 周炳娟, 张金库, 舒准. Turcot综合征1例[J]. 国际肿瘤学杂志, 2022, 49(4): 252-254.

图/表2

参考文献23

[1]	Turcot J, Despres JP, St Pierre F. Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases[J]. Dis Colon Rectum, 1959, 2: 465-468. DOI: 10.1007/BF02616938. doi:10.1007/BF02616938
[2]	Lynch HT, de la Chapelle A. Hereditary colorectal cancer[J]. N Engl J Med, 2003, 348(10): 919-932. DOI: 10.1056/NEJMra012242. doi:10.1056/NEJMra012242
[3]	Khattab A, Monga DK. Turcot syndrome[M]// Treasure Island (FL): StatPearls Publishing, 2021.
[4]	Paraf F, Jothy S, Van Meir EG. Brain tumor-polyposis syndrome: two genetic diseases?[J]. J Clin Oncol, 1997, 15(7): 2744-2758. DOI: 10.1200/JCO.1997.15.7.2744. doi:10.1200/JCO.1997.15.7.2744pmid:9215849
[5]	Vijapura C, Saad Aldin E, Capizzano AA, et al. Genetic syndromes associated with central nervous system tumors[J]. Radiographics, 2017, 37(1): 258-280. DOI: 10.1148/rg.2017160057. doi:10.1148/rg.2017160057pmid:27911673
[6]	Ozerov SS, Zakharov IV, Talypov SR, et al. Turcot syndrome. Rare observation and literature review[J]. Zh Vopr Neirokhir Im N N Burdenko, 2013, 77(3): 49-53.
[7]	从志杰, 刘连杰, 傅传刚. 胶质瘤息肉病综合征[J]. 中国普通外科杂志, 2009, 18(4): 394-396.
[8]	Ninclaus VGS, Walraedt S, Baert E, et al. Diplopia as presenting sign of Turcot syndrome[J]. Int Ophthalmol, 2017, 37(1): 275-278. DOI: 10.1007/s10792-016-0246-z. doi:10.1007/s10792-016-0246-z
[9]	Radin DR, Fortgang KC, Zee CS, et al. Turcot syndrome: a case with spinal cord and colonic neoplasms[J]. AJR Am J Roentgenol, 1984, 142(3): 475-476. DOI: 10.2214/ajr.142.3.475. doi:10.2214/ajr.142.3.475
[10]	张淑红, 朱红, 周小鸽, 等. Turcot综合征合并肠道Burkitt淋巴瘤的临床病理观察[J]. 诊断病理学杂志, 2012, 19(4): 270-273. DOI: 10.3969/j.issn.1007-8096.2012.04.011. doi:10.3969/j.issn.1007-8096.2012.04.011
[11]	Ma S, Hu Y, Yang J, et al. Turcot’s syndrome associated with intestinal non-Hodgkin’s lymphoma: case report and review of literature[J]. Clin Neurol Neurosurg, 2013, 115(2): 117-120. DOI: 10.1016/j.clineuro.2012.04.026. doi:10.1016/j.clineuro.2012.04.026
[12]	Cavenee WK, Burger PC, van Meir EG. Turcot syndrome[A]. WHO classification of tumours. Pathology and genetics of tumours of the nervous system[M]. Lyon: IARC, 2000: 238-239.
[13]	Bisgaard ML, Bülow S. Familial adenomatous polyposis (FAP): genotype correlation to FAP phenotype with osteomas and sebaceous cysts[J]. Am J Med Genet A, 2006, 140(3): 200-204. DOI: 10.1002/ajmg.a.31010. doi:10.1002/ajmg.a.31010pmid:16411234
[14]	Tamiya T, Hamazaki S, Ono Y, et al. Ganglioglioma in a patient with Turcot syndrome. Case report[J]. J Neurosurg, 2000, 92(1): 170-175. DOI: 10.3171/jns.2000.92.1.0170. doi:10.3171/jns.2000.92.1.0170pmid:10616098
[15]	Barreda Costa C, Chu Revollar L, Herrera Alzamora A. Meduloblastoma and recurrent meningioma in association with colonic polyposis: an unusual presentation of Turcot syndrome[J]. Rev Gastroenterol Peru, 2019, 39(3): 280-283. pmid:31688854
[16]	Onilude OE, Lusher ME, Lindsey JC, et al. APC and CTNNB1 mutations are rare in sporadic ependymomas[J]. Cancer Genet Cytogenet, 2006, 168(2): 158-161. DOI: 10.1016/j.cancergen-cyto.2006.02.019. doi:10.1016/j.cancergen-cyto.2006.02.019
[17]	Fritch Lilla SA, Yi JS, Hall BA, et al. A novel APC gene mutation associated with a severe phenotype in a patient with Turcot syndrome[J]. J Pediatr Hematol Oncol, 2014, 36(3): e177-e179. DOI: 10.1097/MPH.0000000000000009. doi:10.1097/MPH.0000000000000009
[18]	Itoh H, Hirata K, Ohsato K. Turcot’s syndrome and familial adenomatous polyposis associated with brain tumor: review of related literature[J]. Int J Colorectal Dis, 1993, 8(2): 87-94. DOI: 10.1007/BF00299334. doi:10.1007/BF00299334pmid:8409693
[19]	Groen EJ, Roos A, Muntinghe FL, et al. Extra-intestinal manifestations of familial adenomatous polyposis[J]. Ann Surg Oncol, 2008, 15(9): 2439-2450. DOI: 10.1245/s10434-008-9981-3. doi:10.1245/s10434-008-9981-3pmid:18612695
[20]	Ramachandra C, Challa VR, Shetty R. Constitutional mismatch repair deficiency syndrome: do we know it?[J]. Indian J Hum Genet, 2014, 20(2): 192-194. DOI: 10.4103/0971-6866.142902. doi:10.4103/0971-6866.142902pmid:25400351
[21]	Stoffel EM, Mangu PB, Gruber SB, et al. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines[J]. J Clin Oncol, 2015, 33(2): 209-217. DOI: 10.1200/JCO.2014.58.1322. doi:10.1200/JCO.2014.58.1322pmid:25452455
[22]	Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot’s syndrome[J]. N Engl J Med, 1995, 332(13): 839-847. DOI: 10.1056/NEJM199503303321302. doi:10.1056/NEJM199503303321302
[23]	Bruwer Z, Algar U, Vorster A, et al. Predictive genetic testing in children: constitutional mismatch repair deficiency cancer predisposing syndrome[J]. J Genet Couns, 2014, 23(2): 147-155. DOI: 10.1007/s10897-013-9659-2. doi:10.1007/s10897-013-9659-2

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表2

参考文献23

相关文章15

编辑推荐

Metrics

本文评价

[1]	张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[2]	高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[3]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[4]	孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹.结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118.
[5]	刘德宝, 孙子雯, 鲁守堂, 徐海东.ASB6在结直肠癌组织中的表达及临床意义[J]. 国际肿瘤学杂志, 2023, 50(8): 470-474.
[6]	陈卓, 陶俊, 陈琳, 柯晶.外周血miR-194联合粪便miR-143检测对结直肠癌临床筛查的价值[J]. 国际肿瘤学杂志, 2023, 50(5): 268-273.
[7]	黄镇, 张蔡羽天, 柯少波, 石薇, 赵文思, 陈永顺.结直肠癌患者术后预后模型的构建[J]. 国际肿瘤学杂志, 2023, 50(3): 157-163.
[8]	徐良富, 李袁飞.MSS型结直肠癌肿瘤微环境及免疫联合治疗研究进展[J]. 国际肿瘤学杂志, 2023, 50(3): 186-190.
[9]	刘玉杰, 赵志强, 王子琤.早期结直肠癌患者外周血单个核细胞中TOP2A、ERBB2的水平及其诊断价值[J]. 国际肿瘤学杂志, 2023, 50(12): 717-722.
[10]	陶红, 殷红, 罗宏, 陶佳瑜.靶向肿瘤相关巨噬细胞增强结直肠癌免疫检查点抑制剂疗效的潜在策略[J]. 国际肿瘤学杂志, 2023, 50(11): 683-687.
[11]	王熙, 吴川清.结直肠癌多药耐药逆转的研究进展[J]. 国际肿瘤学杂志, 2023, 50(1): 42-46.
[12]	高一钊, 刘洋, 刘秋龙, 邢金良.循环游离核酸在结直肠癌临床诊疗中的应用[J]. 国际肿瘤学杂志, 2022, 49(9): 555-559.
[13]	何哲锋, 吴燚阳, 李振军, 应晓江.炎性相关标志物对结直肠癌的预测价值[J]. 国际肿瘤学杂志, 2022, 49(9): 560-563.
[14]	赵莹, 张革红.AGR、PLR及NLR变化与转移性结直肠癌化疗疗效的相关性研究[J]. 国际肿瘤学杂志, 2022, 49(8): 473-477.
[15]	黄梦盼, 王学红, 芦永福.FOXA2在结直肠癌中的作用机制及其在诊疗中的作用[J]. 国际肿瘤学杂志, 2022, 49(8): 490-493.